Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast (Targeted Oncology, (2023), 18, 6, (807-817), 10.1007/s11523-023-00994-2)

Xiuning Le, Eric Nadler, Daniel B. Costa, John Victor Heymach

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast (Targeted Oncology, (2023), 18, 6, (807-817), 10.1007/s11523-023-00994-2)'. Together they form a unique fingerprint.

Medicine & Life Sciences